This is the transcatheter mitral valve replacement device under an FDA early feasibility study conducted by Minneapolis Heart Institute Foundation®. Disclaimer: AAAS and EurekAlert! are not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback